Revive Therapeutics (FRA:31R) 3-Year EBITDA Growth Rate

: -37.80% (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

Revive Therapeutics's EBITDA per Share for the three months ended in Dec. 2022 was €-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -37.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Revive Therapeutics was 42.60% per year. The lowest was -37.80% per year. And the median was -2.30% per year.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Revive Therapeutics 3-Year EBITDA Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's 3-Year EBITDA Growth Rate falls in comparison to its industry or sector. The grey bar indicates the 3-Year EBITDA Growth Rate's extreme value range as defined by GuruFocus.

Revive Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Revive Therapeutics (FRA:31R) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Revive Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (FRA:31R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (FRA:31R) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

RVVTF:USA RVV:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Revive Therapeutics (FRA:31R) Headlines

No Headlines